Defibrillators Market, by Product Type (Implantable Cardioverter Defibrillators (Single Chamber Implantable Cardioverter Defibrillators and Dual Cardioverter Defibrillators) and External Defibrillators (Manual External Defibrillators, Automated External D

Defibrillators Market, by Product Type (Implantable Cardioverter Defibrillators (Single Chamber Implantable Cardioverter Defibrillators and Dual Cardioverter Defibrillators) and External Defibrillators (Manual External Defibrillators, Automated External Defibrillators, and Wearable Cardioverter Defibrillators)), by End User (Hospitals, Cardiac Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Defibrillation is a technique that is considered as a definitive treatment of cardiac arrests and arrhythmias. Defibrillators are devices that are used to defibrillate or stabilize the heartbeat of the patient in a condition of arrhythmias and ventricular tachycardia. The major function of defibrillation in ventricular arrhythmias is to apply a controlled electrical shock to the heart, which leads to the depolarization of the electrical conduction system of the heart. After the heart is polarized the normal electrical conduction is attained, thus terminating ventricular arrhythmia. A shock from a personal defibrillator can be painless. People who are at high risk for a life-threatening heart rhythm may have these defibrillator types’ namely wearable cardioverter defibrillator and implantable cardioverter defibrillator.

Market Dynamics

High incidence of cardiac disorders along with increasing technological advancements in defrillators, and healthcare expenditure by government and non-government organization are major factors driving the global defibrillators market growth. For instance in 2019, according to the Center for Medicare and Medicaid Services’ report, the national healthcare expenditure is projected to increase by 4.8% in 2019, up from 4.4% in 2018, to reach US$ 3.8 trillion in the U.S.

Furthermore, key players in market are focused on adopting growth strategies such as mergers and acquisitions and product development to expand their product portfolio, which is expected to drive the market growth. For instance, in June 2019, Koninklijke Philips N.V. received U.S. Food and Drug Administration (FDA) premarket approvals for automated external defibrillators, HeartStart OnSite defibrillator and HeartStart Home defibrillator.

Key features of the study:

• This report provides an in-depth analysis of the global defibrillators market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global defibrillators market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Koninklijke Philips N.V., Metrax GmbH, Mindray Medical International Limited, Boston Scientific Corporation, GE Healthcare, Nihon Kohden, Abbott, BIOTRONIK, and LivaNova PLC
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global defibrillators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global defibrillators market

Detailed Segmentation:

• Global Defibrillators Markets, By Product Type:
• Implantable Cardioverter Defibrillators
• Single Chamber Implantable Cardioverter Defibrillators
• Dual Chamber Implantable Cardioverter Defibrillators
• External Defibrillators
• Manual External Defibrillators
• Automated External Defibrillators
• Wearable Cardioverter Defibrillators
• Global Defibrillators Markets, By End User:
• Hospitals
• Cardiac Clinics
• Ambulatory Surgical Centers
• Global Defibrillators Markets, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Region/Country
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Koninklijke Philips N.V.*
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Metrax GmbH
• Medtronic
• Mindray Medical International Limited
• Boston Scientific Corporation
• GE Healthcare
• Nihon Kohden
• Abbott
• BIOTRONIK
• Stryker
• LivaNova PLC

“*” marked represents similar segmentation in other categories in the respective section.